Last reviewed · How we verify

NCT05301556

Food for Special Medical Purpose in Patients With Digestive Tract Tumor

Completed NA Last updated 1 March 2024
What this trial tests

NA trial testing Experimental Product in Gastrointestinal Cancer in 326 participants. Completed in 9 January 2024.

Timeline
24 June 2022
Primary endpoint
9 January 2024
9 January 2024

Quick facts

Lead sponsorAbbott Nutrition
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment326
Start date24 June 2022
Primary completion9 January 2024
Estimated completion9 January 2024
Sites8 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

Abbott Nutrition — full company profile →

Who can join

Adults 18 to 75, any sex, with Gastrointestinal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, randomized, controlled, unblinded, parallel, multicenter, and non-inferiority study to demonstrate the safety and efficacy of a Food for Special Medical Purpose product (FSMP) in participants with digestive tract tumor undergoing surgical resection during the perioperative period.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Dietary inflammatory index and unfavorable dietary patterns associated with ischemic stroke in China.
    Yu J, Chen W, Xiao G, An Q, et al · · 2026 · PMID 42242853 · DOI 10.6133/apjcn.202606_35(3).0009

Verify or expand the search:

Other trials of Experimental Product

Trials testing the same drug.

Other recruiting trials for Gastrointestinal Cancer

Currently open trials in the same condition.

Other Abbott Nutrition trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05301556.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing